Stratifying Newly Diagnosed ATTR CM Patients скачать в хорошем качестве

Stratifying Newly Diagnosed ATTR CM Patients

Kevin Alexander, MD, of Stanford Medicine, explains that stratifying newly diagnosed ATTR CM patients begins with understanding their functional status, including daily activity limitations and heart failure symptoms. He highlights the usefulness of the NAC staging system—combining NT proBNP levels and renal function—to estimate prognosis. Practical clinical indicators such as rising diuretic needs, repeated heart failure hospitalizations, and worsening biomarkers often signal disease progression. While no single lab value predicts rapid decline, Dr. Alexander emphasizes integrating biomarker trends, heart failure severity, patient reported functional changes, and recent clinical events to guide therapy adjustments and determine when to escalate or add treatments.